Sign in to continue:

Tuesday, February 3rd, 2026

Morningstar’s 10 Cheapest Wide-Moat US Stocks for 2025: Estee Lauder, Pfizer, Nike Lead the Pack

Morningstar Equity Research has unveiled its 10 “cheap, wide-moat” US stocks for 2025, spotlighting companies with strong competitive advantages that enable them to fend off rivals and deliver long-term value to investors.

What Are Wide-Moat Stocks?

Wide-moat stocks represent companies with enduring competitive edges built through strategies like:

  • High switching costs for customers.
  • Iconic brand identities that inspire loyalty.
  • Economies of scale that keep costs low and profitability high.

These companies also boast sound balance sheets, making them desirable picks amid today’s economic uncertainties, says Susan Dziubinski, an investment specialist at Morningstar. She notes that investing in wide-moat stocks trading at a discount to their fair value has historically been a successful strategy.

The Top 10 Undervalued Wide-Moat Stocks

As of Dec 27, 2024, the 10 most undervalued wide-moat stocks, according to the Morningstar Wide Moat Focus Index, are:

  1. Estee Lauder (EL)
    • Trading 54% below fair value, making it the most undervalued on the list.
    • Its shares have fallen 47% in 2024, closing at US$73.98 on Jan 2.
  2. Huntington Ingalls Industries (HII)
  3. Pfizer (PFE)
  4. International Flavors & Fragrances (IFF)
    • The only stock with a price increase in 2024, up 2.05% year-on-year.
  5. Nike (NKE)
  6. Campbell Company (CPB)
    • Shares declined the least, falling just 6% to US$42.03.
  7. Brown-Forman (BF.B)
  8. Zimmer Biomet (ZBH)
  9. NXP Semiconductors (NXPI)
  10. MarketAxess Holdings (MKTX)
    • Trading 25% below fair value, the least undervalued stock on the list.

Why These Stocks Matter

“These wide-moat stocks represent high-quality opportunities for long-term investors, particularly those looking for discounted investments,” says Dziubinski. Companies like Estee Lauder and Pfizer bring a combination of resilience and growth potential, making them compelling picks for 2025.

Performance in 2024

The list reflects diverse performance:

  • Biggest decline: Estee Lauder’s shares tumbled 47% in 2024.
  • Steady performers: Campbell’s Co weathered the storm, dropping just 6%.
  • Notable growth: International Flavors & Fragrances bucked the trend, gaining 2.05%.

An Investment Opportunity

While markets face uncertainties, Morningstar believes these stocks are positioned to thrive in the long run. With sound fundamentals and significant discounts to fair value, they offer investors a chance to buy into companies with decades of competitive dominance at compelling prices.

For long-term value hunters, Morningstar’s wide-moat picks could be the cornerstone of a resilient portfolio in 2025.

Thank you

OUE REIT (SGX: OUEI) 2025 Outlook: Steady Growth, Strong Dividend Yield & Resilient Portfolio – Buy Rating Maintained

Broker: OCBC Investment Research Date of Report: 24 July 2025 OUE REIT: Navigating Uncertainty with Resilience and Growth – A Comprehensive Analysis Overview: OUE REIT’s Steady Performance Amid Market Volatility OUE Real Estate Investment...

“Golden Agri-Resources 2025 Update: Strong Recovery, Dividend Growth, and CPO Price Outlook”

Overview This report provides an in‐depth analysis of Golden Agri‑Resources (GAR), one of the world’s leading integrated palm oil plantation companies, and reviews its key peers – Wilmar International Ltd and First Resources Ltd....

OCBC Downgraded to Hold: FY25 Earnings Growth Under Pressure – Analyst Report

Broker Name: CGS International Date of Report: April 23, 2025 OCBC Downgraded to Hold: Earnings Growth Under Pressure Amidst Economic Uncertainty OCBC Stock Analysis CGS International has downgraded Oversea-Chinese Banking Corporation (OCBC) to a...